Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Mueller

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Cancer Research|June 1, 1995
Therapeutic efficacy of a doxorubicin immunoconjugate in a preclinical model of spontaneous metastatic human melanomaG P Sivam, P J Martin, R A Reisfeld, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1990
Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibodyB M Mueller, C A Romerdahl, S D Gillies, et al.
The Journal of Clinical Investigation|June 1, 1992
Involvement of integrin alpha V gene expression in human melanoma tumorigenicityB Felding-Habermann, B M Mueller, C A Romerdahl, et al.
Cancer Research|April 15, 1991
Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptorB M Mueller, C A Romerdahl, J M Trent, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1992
Role of alpha V integrins and vitronectin in human melanoma cell growthL C Sanders, B Felding-Habermann, B M Mueller, et al.
The Journal of Cell Biology|April 18, 1998
A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280I Ott, E G Fischer, Y Miyagi, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1993
Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanomaM Naramura, S D Gillies, J Mendelsohn, et al.
Immunology Letters|December 1, 1993
Mechanisms of cellular cytotoxicity mediated by a recombinant antibody-IL2 fusion protein against human melanoma cellsM Naramura, S D Gillies, J Mendelsohn, et al.
Progress in Brain Research|January 1, 1994
Potential of genetically engineered anti-ganglioside GD2 antibodies for cancer immunotherapyR A Reisfeld, B M Mueller, R Handgretinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 1994
A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency miceH Sabzevari, S D Gillies, B M Mueller, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Cancer Research|June 1, 1995
Therapeutic efficacy of a doxorubicin immunoconjugate in a preclinical model of spontaneous metastatic human melanomaG P Sivam, P J Martin, R A Reisfeld, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1990
Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibodyB M Mueller, C A Romerdahl, S D Gillies, et al.
The Journal of Clinical Investigation|June 1, 1992
Involvement of integrin alpha V gene expression in human melanoma tumorigenicityB Felding-Habermann, B M Mueller, C A Romerdahl, et al.
Cancer Research|April 15, 1991
Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptorB M Mueller, C A Romerdahl, J M Trent, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1992
Role of alpha V integrins and vitronectin in human melanoma cell growthL C Sanders, B Felding-Habermann, B M Mueller, et al.
The Journal of Cell Biology|April 18, 1998
A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280I Ott, E G Fischer, Y Miyagi, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1993
Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanomaM Naramura, S D Gillies, J Mendelsohn, et al.
Immunology Letters|December 1, 1993
Mechanisms of cellular cytotoxicity mediated by a recombinant antibody-IL2 fusion protein against human melanoma cellsM Naramura, S D Gillies, J Mendelsohn, et al.
Progress in Brain Research|January 1, 1994
Potential of genetically engineered anti-ganglioside GD2 antibodies for cancer immunotherapyR A Reisfeld, B M Mueller, R Handgretinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 1994
A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency miceH Sabzevari, S D Gillies, B M Mueller, et al.
Pageof 5